Literature DB >> 31792406

Dissecting the benefits of sacubitril-valsartan for heart failure.

Irene Fernández-Ruiz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31792406     DOI: 10.1038/s41569-019-0322-y

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  3 in total

Review 1.  Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.

Authors:  Javed Butler; Milton Packer; Stephen J Greene; Mona Fiuzat; Stefan D Anker; Kevin J Anstrom; Peter E Carson; Lauren B Cooper; Gregg C Fonarow; Adrian F Hernandez; James L Januzzi; Mariell Jessup; Rita R Kalyani; Sanjay Kaul; Mikhail Kosiborod; JoAnn Lindenfeld; Darren K McGuire; Marc S Sabatine; Scott D Solomon; John R Teerlink; Muthiah Vaduganathan; Clyde W Yancy; Norman Stockbridge; Christopher M O'Connor
Journal:  Circulation       Date:  2019-12-16       Impact factor: 29.690

2.  Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus.

Authors:  Muthiah Vaduganathan; Gregg C Fonarow; Stephen J Greene; Adam D DeVore; Nancy M Albert; Carol I Duffy; C Larry Hill; John A Spertus; Laine E Thomas; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2019-11-11       Impact factor: 24.094

3.  Baseline Characteristics of the VANISH Cohort.

Authors:  Anna Axelsson Raja; Ling Shi; Sharlene M Day; Mark Russell; Kenneth Zahka; Harry Lever; Steven D Colan; Renee Margossian; E Kevin Hall; Jason Becker; John Lynn Jefferies; Amit R Patel; Lubna Choudhury; Anne M Murphy; Charles Canter; Richard Bach; Matthew Taylor; Luisa Mestroni; Matthew T Wheeler; Lee Benson; Anjali T Owens; Joseph Rossano; Kimberly Y Lin; Elfriede Pahl; Alexandre C Pereira; Henning Bundgaard; Gregory D Lewis; Jose D Vargas; Allison L Cirino; John J V McMurray; Calum A MacRae; Scott D Solomon; E John Orav; Eugene Braunwald; Carolyn Y Ho
Journal:  Circ Heart Fail       Date:  2019-12-09       Impact factor: 8.790

  3 in total
  1 in total

1.  LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats.

Authors:  Toru Miyoshi; Kazufumi Nakamura; Naofumi Amioka; Omer F Hatipoglu; Tomoko Yonezawa; Yukihiro Saito; Masashi Yoshida; Satoshi Akagi; Hiroshi Ito
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.